Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, and strategic partnerships further drive expansion in this evolving sector. Asia-Pacific offers cost-effective growth. Precision medicine, chronic disease prevalence, a…
The controlled release drug delivery market is poised for growth driven by increased R&D, technological advances, and demand for convenient, effective chronic disease treatments. Key opportunities include aging populations, cost-efficient generics, and expand…